A

Alector
D

ALEC

1.80000
USD
-0.01
(-0.55%)
Market Closed
Volume
0
EPS
-2
Div Yield
-
P/E
-1
Market Cap
176,278,689
News

Title: Alector

Sector: Healthcare
Industry: Biotechnology
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.